# Evaluation of the Effectiveness and Safety of ABAStroke

Study · id `cardio:ct-nct05979324` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05979324](<https://clinicaltrials.gov/study/NCT05979324>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05979324

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05979324. Randomized; no masking; primary purpose treatment. Start 2023-07-13 (actual); primary completion 2023-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05979324, source copy `cardio:ctgov-nct05979324-2023-08-07`, retrieved 2026-10-26)
- Started: 2023-07-13 (actual) (ClinicalTrials.gov record NCT05979324, source copy `cardio:ctgov-nct05979324-2023-08-07`, retrieved 2026-10-26)
- Primary completion: 2023-12-31 (anticipated) (ClinicalTrials.gov record NCT05979324, source copy `cardio:ctgov-nct05979324-2023-08-07`, retrieved 2026-10-26)
- Completion: 2024-05-31 (anticipated) (ClinicalTrials.gov record NCT05979324, source copy `cardio:ctgov-nct05979324-2023-08-07`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT05979324, source copy `cardio:ctgov-nct05979324-2023-08-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05979324-2023-08-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of the Effectiveness and Safety of ABAStroke
- Condition: Stroke
- Intervention (Device): ABAStroke Digital Therapeutics
- Lead sponsor: ABAStroke Sp. z o.o.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 8de4b448f4e90b978eadaacb59d8eb7192a8d510bd796501016d8b72700a065d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
